Log in using OpenID

Life Cell Imaging Market Value Projected to Expand by 2018-2026

The Global Life Cell Imaging Market was valued at US$ 4.4 billion in 2016 and is expected to witness a robust CAGR of 8.60% over the forecast period (2017 - 2025). The global life cell imaging industry has observed a notable growth over the last few
Life Cell Imaging Market Trends Estimates High
Demand by 2026
Global Life Cell Imaging Market, by Product Type (Instruments and
Consumables), by Modality (Portable and Standalone), by End-use Industry
(Hospitals, Research Laboratories, Biotechnology Companies and
Pharmaceutical Companies) and by Region - Trends, and Forecast till 2025
The Global Life Cell Imaging Market was valued at US$ 4.4 billion in 2016 and is expected to
witness a robust CAGR of 8.60% over the forecast period (2017 - 2025).
The global life cell imaging industry has observed a notable growth over the last few decades due to
significant increase in the demand for life cell imaging techniques for the study of cancer, neuroscience
and drug discovery. Cellular imaging involves use of techniques that enable the detection and analysis
of cellular organelles and macromolecules through light- or electron-based microscopes. Cell imaging
is rapidly evolving as new technologies are being introduced such as light sheet microscopy, intra-vital
microscopy, environmental scanning electron microscopy and high throughput microscopy.
Furthermore, life cell imaging use fluorophore labeled molecules, fluorescent dyes and recombinant
plasmid systems for imaging expression, transport, co-localization and degradation in either living or
fixed cells. In addition, cellular structures and functions can be visually detected using methods such as
wide field fluorescence and fluorescence resonance energy transfer (FRET) microscopy.
Market Dynamics
The life cell imaging market is gaining significant traction due to rising adoption of techniques in
various fields such as stem cell biology, neurobiology, developmental biology, cell biology, and
oncology, drug discovery, and electro physiology. Furthermore, life cell imaging has emerged as a
potential tool that helps provide insights into dynamic processes in living cells and cell function with
the help of agents such as green fluorescent protein (GFP) and multicolored probes that precisely label
molecules and directly probe its function in live cells by light microscopy. Due to the visualization
ability of the imaging tools, the dynamics of protein vesicles, organelles, cells and tissue has provided
new insights into how cells function. However, the factors such as shortage of skilled professionals and
high cost of the advanced microscopes hinder market growth to a certain extent.
Cellular imaging refers to the techniques that allows the detection and analysis of various cellular
organelles and macromolecules using a light-based or electron based microscopes. These are then
mainly analyzed through computer based programs. Apart from the structural organization and
orientation of organs and cells in organisms, dynamic processes contributes a major part in
understanding the function and mechanism of a biological entity. Live life cell imaging refers to the
non-invasive techniques such as optical methods that help visualize functional behavior of the cells
with the help of high-end imaging instruments such as stereo microscopes. The high-content screening
systems have become a popular analytical tool for elucidation of biological mechanisms as well as for
the study of dynamic functions of the cells. The life cell imaging systems are used in order to study the
living cells through the images obtained from life cell imaging instruments.
Ask For Sample Copy Of This Business Research Report :
Competitive Analysis
The major players operating global life cell imaging market includes Leica Microsystems, Carl Zeiss
Meditec AG, Nikon Instruments, Inc., Thermofisher Scientific, Inc., Olympus Corporation, GE
Healthcare, Sigma-Aldrich Corporation, Molecular Devices LLC, PerkinElmer, Inc. and BectonDickinson and Company.
Rise in development of cancer drugs is a crucial factor to propel the market growth
Accelerating drug development has become a crucial factor so as to come up with new and advanced
drugs that has potential to treat cancer. Understanding the cellular functionality of these oncogenic
substances and tumor cells is thus a very important step in the drug development and requires highpowered microscopes to understand the dynamic structures so as to develop a drug against the cancer
causing agents. The government as well as various federal agencies play important roles funding
imaging systems to support and clinical care and research. For instance, the National Science and
Technology Council, which is an Interagency Working Group on Medical Imaging (IWGMI)
established in 2015 develops a roadmap for medical-imaging research and development in the U.S. that
helps in generating better outcome of healthcare and optimize the costs.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
ravikiran303   documents Email
Health and Medicine
File Size
365 KB
Report inappropriate content